In these studies, the amount of 5-amino-1MQ administered was 10-20 mg/kg per day, allowing for precise measurement of its effect
So, we have seen this coming over the years
John Wilding
Such methodological limitations introduce potential confounding factors, particularly when additional glucose-lowering therapies, such as insulin or metformin, are co-administered
When the intestines are dehydrated, there isnt enough water to add to the stools, resulting in dry, hard lumps (referred to as type 1 stools in the Bristol Stool Chart)
In lower income neighborhoods, where rates of type 2 diabetes and obesity are higher, the usage rate of GLP-1s was around half of what it was in the most affluent areas of New York City